|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.00 ARS | +2.53% |
|
-1.22% | -32.64% |
| Market Cap | 6.9B 4.63M 4.05M 3.73M 3.46M 6.58M 441M 6.67M 44.67M 17.38M 217M 17.37M 16.99M 751M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.64B 5.12M 4.48M 4.13M 3.83M 7.28M 488M 7.38M 49.44M 19.24M 240M 19.23M 18.81M 831M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.53% | ||
| 1 week | -1.22% | ||
| Current month | -0.61% | ||
| 1 month | +0.31% | ||
| 3 months | -14.96% | ||
| 6 months | -26.70% | ||
| Current year | -32.64% |
| 1 week | 155 | 165.5 | |
| 1 month | 155 | 171.5 | |
| Current year | 128.5 | 260 | |
| 1 year | 116 | 357 | |
| 3 years | 21 | 450 | |
| 5 years | 9.1 | 450 | |
| 10 years | 4.2 | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 2010-07-29 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2010-07-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.53% | -1.22% | +15.10% | +636.36% | 4.63M | ||
| +0.83% | +2.96% | -52.62% | -55.23% | 31.62B | ||
| +0.52% | +1.58% | +71.65% | +156.17% | 12.55B | ||
| -0.47% | +6.04% | -12.82% | +4.98% | 3.82B | ||
| +0.77% | -1.50% | -1.36% | +31.00% | 3.11B | ||
| +3.49% | +7.51% | +57.87% | +33.96% | 2.05B | ||
| +1.08% | +4.45% | -26.96% | +19.61% | 1.66B | ||
| +2.62% | +7.29% | +21.89% | +134.89% | 1.38B | ||
| +1.65% | +7.60% | -18.91% | -8.00% | 1.07B | ||
| +1.40% | +2.40% | -2.94% | -17.22% | 950M | ||
| Average | +1.39% | +3.59% | +5.09% | +93.65% | 5.82B | |
| Weighted average by Cap. | +0.55% | +2.96% | -12.65% | +10.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.55M 4.86M 4.48M 4.15M 7.89M 529M 8M 53.57M 20.85M 260M 20.84M 20.38M 901M | 6.4B 4.29M 3.76M 3.46M 3.21M 6.1M 410M 6.19M 41.46M 16.13M 201M 16.12M 15.77M 697M |
| Net income | -1.42B -950K -832K -767K -712K -1.35M -90.64M -1.37M -9.18M -3.57M -44.49M -3.57M -3.49M -154M | -4.6B -3.08M -2.7M -2.49M -2.31M -4.38M -294M -4.44M -29.77M -11.58M -144M -11.58M -11.32M -500M |
| Net Debt | 863M 579K 507K 467K 433K 823K 55.2M 834K 5.59M 2.17M 27.1M 2.17M 2.13M 93.95M | 738M 495K 433K 399K 370K 703K 47.18M 713K 4.78M 1.86M 23.16M 1.86M 1.82M 80.3M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | ARS 162.00 | +2.53% | 14,507 |
| 26-07-03 | ARS 158.00 | -3.07% | 3,769 |
| 26-07-02 | ARS 163.00 | 0.00% | 9,583 |
| 26-07-01 | ARS 163.00 | 0.00% | 11,988 |
| 26-06-30 | ARS 163.00 | -0.61% | 17,133 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
















